Atrial fibrillation - dabigatran etexilate: consultee and commentator comments on the ACD
Atrial fibrillation - dabigatran etexilate: AntiCoagulation Europe (ACE) comments on the ACD
Atrial fibrillation - dabigatran etexilate: Arrhythmia Alliance comments on the ACD
Atrial fibrillation - dabigatran etexilate: Atrial Fibrillation Association comments on the ACD
Atrial fibrillation - dabigatran etexilate: Bayer comments on the ACD
Atrial fibrillation - dabigatran etexilate: Boehringer Ingelheim comments on the ACD
Atrial fibrillation - dabigatran etexilate: Bristol Myers-Squibb & Pfizer comments on the ACD
Atrial fibrillation - dabigatran etexilate: British Cardiovascular Intervention Society comments on the ACD
Atrial fibrillation - dabigatran etexilate: Commissioning Support & Appraisal Service comments on the ACD
Atrial fibrillation - dabigatran etexilate: Department of Health comments on the ACD
Atrial fibrillation - dabigatran etexilate: Heart Rhythm UK comments on the ACD
Atrial fibrillation - dabigatran etexilate: NHS Salford comments on the ACD
Atrial fibrillation - dabigatran etexilate: Royal College of Nursing comments on the ACD
Atrial fibrillation - dabigatran etexilate: Royal College of Physicians comments on the ACD
This page was last updated: 31 October 2011